PH Form 4: Mark T. Czaja Granted 3,232 Stock Appreciation Rights
Rhea-AI Filing Summary
Parker-Hannifin officer Mark T. Czaja received a Stock Appreciation Rights (SAR) award for 3,232 shares on 08/20/2025. The SARs have a grant reference value of $742.97 and were reported as an acquisition. The award becomes exercisable in three equal annual installments beginning 08/20/2026 and expires on 08/19/2035. Following the reported grant, Mr. Czaja is shown as the direct beneficial owner of 3,232 underlying common shares tied to the SARs. The Form 4 was filed by one reporting person and signed by an attorney-in-fact.
Positive
- None.
Negative
- None.
Insights
TL;DR: A mid-level executive SAR grant of 3,232 shares vests over three years; routine compensation, limited immediate dilution.
The grant of Stock Appreciation Rights to the VP-Chief Technology & Innovation is a standard long-term incentive aligning the executive with shareholder value appreciation. The SARs are exercisable beginning one year after grant in three equal annual installments, which staggers potential dilution and retention incentives. The grant’s grant-price reference of $742.97 indicates the base for appreciation, and the reported amount of 3,232 underlying shares represents the maximum common shares deliverable on exercise. This disclosure appears routine and nondilutive in the near term absent immediate exercise.
TL;DR: Filing documents a typical officer equity award with standard vesting and a long expiration; disclosure is complete for Form 4 purposes.
The Form 4 provides required details: transaction date, award type, number of SARs, exercisability schedule, expiration, and direct beneficial ownership after the grant. The use of an attorney-in-fact signature is properly noted. There are no indications of related-party transactions, amendments, or accelerated vesting reported. For governance assessment, this appears as routine compensation disclosure without material governance concerns disclosed in the form.